Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001187443-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-11 | 2026-02-09 | REGN | RYAN ARTHUR F | Dir | S - Sale | $778.53 | -100 | 17.9K | -0.6% | -$77.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-09 | S | D | 5 | $779.41 | 17,818 | D | — | — | (F5) Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $779.13 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
| 2 | Common | Common Stock | 2026-02-09 | S | D | 1 | $780.09 | 17,817 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-09 | S | D | 5 | $781.48 | 17,812 | D | — | — | (F6) Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $781.05 to $781.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
| 4 | Common | Common Stock | 2026-02-09 | S | D | 1 | $782.53 | 17,811 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-09 | S | D | 3 | $783.34 | 17,808 | D | — | — | (F7) Represents volume-weighted average price of sales of 3 shares of Company stock on February 9, 2026 at prices ranging from $783.20 to $783.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
| 6 | Common | Common Stock | 2026-02-09 | S | D | 1 | $784.59 | 17,807 | D | — | — | |
| 7 | Common | Common Stock | 2026-02-09 | S | D | 1 | $785.71 | 17,806 | D | — | — | |
| 8 | Common | Common Stock | 2026-02-09 | S | D | 2 | $786.29 | 17,804 | D | — | — | |
| 9 | Common | Common Stock | 2026-02-09 | S | D | 1 | $787.82 | 17,803 | D | — | — | |
| 10 | Common | Common Stock | 2026-02-09 | S | D | 12 | $778.53 | 17,823 | D | — | — | (F4) Represents volume-weighted average price of sales of 12 shares of Company stock on February 9, 2026 at prices ranging from $778.11 to $778.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
| 11 | Common | Common Stock | 2026-02-09 | S | D | 57 | $777.56 | 17,835 | D | — | — | (F3) Represents volume-weighted average price of sales of 57 shares of Company stock on February 9, 2026 at prices ranging from $777.02 to $777.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
| 12 | Common | Common Stock | 2026-02-09 | S | D | 1 | $775.63 | 17,902 | D | — | — | |
| 13 | Common | Common Stock | 2026-02-09 | S | D | 10 | $776.59 | 17,892 | D | — | — | (F2) Represents volume-weighted average price of sales of 10 shares of Company stock on February 9, 2026 at prices ranging from $776.04 to $776.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |